Loading Events

BACK

December 4, 9:00 am - 10:00 am

Free
Coffee Sessions
Virtual
Coffee Sessions
Virtual

Inside the Ebola Response: From Vaccines and Treatments to Caring for Patients

Click here to register.

 

December 4th Coffee Sessions Promo Image

What does it take to care for patients and stop transmission during an Ebola outbreak, and how does the response change when we are dealing with a strain for which we have far fewer proven tools?

This session will take a closer look at the science and practice of the 2026 Bundibugyo outbreak. Experts will discuss how patients are identified and cared for, how treatment centers are established, how healthcare workers are protected, and how contact tracing, isolation, infection prevention, and community engagement help interrupt transmission. The panel will also explore the rapidly evolving research landscape, including new vaccine candidates and clinical trials testing potential treatments for Bundibugyo virus.

This webinar is free and open to the public and will conclude with a live Q&A session.

 

Speakers

Daniel Bausch Headshot

Daniel Bausch, MD, MPH&TM, FASTMH

Visiting Professor, Geneva Graduate Institute, Switzerland; and Centre for Infectious Disease Emergency Response, National University of Singapore;

Past President and Scientific Program Chair, American Society of Tropical Medicine and Hygiene

Professor Daniel Bausch, MD, MPH&TM, FASTMH, is an internationally recognized leader in global health research, outbreak response, education, and programme implementation. He is trained in internal medicine, infectious diseases, tropical medicine, and public health. Professor Bausch specializes in the control of emerging tropical diseases, with over 25 years’ experience in sub-Saharan Africa, Latin America, and Asia combating viruses such as Ebola, Marburg, Lassa, hantavirus, and SARS coronaviruses. He currently holds appointments as a Visiting Professor at the Geneva Graduate Institute, National University of Singapore, and London School of Hygiene and Tropical Medicine. Previously he held leadership positions as the Senior Advisor for Global Health Security at FIND (Geneva, Switzerland), Director of the United Kingdom Public Health Rapid Support Team (London, UK), Technical Lead of the Epidemic Clinical Management Team at the World Health Organisation (Geneva, Switzerland), Chief of the Virology and Emerging Infections Department at U.S. Naval Medical Research Unit No. 6 (Lima, Peru), Professor at Tulane School of Public Health and Tropical Medicine (New Orleans, USA), and Medical Officer at the U.S. Centers for Disease Control and Prevention (Atlanta, USA). He is a past President and Scientific Program Chair of the American Society of Tropical Medicine and Hygiene. Professor Bausch places a strong emphasis on capacity development in all his projects and has a keen interest in the role of the scientist in promoting health and human rights, striving to ensure that biomedical advances reach and translate to better health for those most in need. He is fluent in English, French, and Spanish.

 

Placide Mbala Kingebeni Headshot

Professor Placide Mbala, MD, MSc, PhD

Director of Research, Clinical Trials and Innovation at Africa CDC

Professor Placide Mbala is an internationally recognized leader in outbreak science, clinical research, and pathogen genomics. A medical doctor, microbiologist, and virologist, he brings more than fifteen years of experience combating emerging and re-emerging viral threats, including Ebola, mpox, COVID-19, and poliovirus, with a particular focus on high-risk and hard-to-reach settings.

He currently leads Africa CDC’s work on African-led research, outbreak science, clinical trials, human and pathogen genomics, diagnostics, vaccines, therapeutics, and evidence-to-policy translation. He joined Africa CDC from the Institut National de Recherche Biomédicale (INRB) in Kinshasa, Democratic Republic of the Congo, where he held senior leadership roles across epidemiology, clinical research, pathogen sequencing, and viral haemorrhagic fevers, and where he led major African research platforms including the EBO-PEP Ebola post-exposure prophylaxis trial, the PARTNERS filovirus therapeutics platform, and the WaSPP wastewater surveillance network.

Professor Mbala has authored more than 100 scientific publications in journals including The New England Journal of Medicine, The Lancet, Nature Medicine, and Nature Microbiology. He was named among Nature’s 10 People Who Shaped Science in 2024 and the TIME100 Health list in 2025. His work advances the science, partnerships, and innovation needed to strengthen Africa’s health security and sovereignty.

Details

Date:
December 4
Time:
9:00 am - 10:00 am
Series:
Cost:
Free
Event Category:

Organizer

Harvard Global Health Institute
Website:
http://globalhealth.harvard.edu
Register

Venue

Virtual

Other

Series Type
Coffee Sessions
Register